UCBJY
UCB SA
Healthcare · Biotechnology · PNK
$140.35
Close 2026-05-23
✓ ETHICAL PASS

MODERATE MOAT
HIGH
Data Confidence: 100%
Full financial profile available
Market Cap
$53.5B
Trailing P/E
30.05
Forward P/E
18.75
Rev Growth
+26.6%
Profit Margin
20.1%
ROE
14.9%
Analyst Target
$163.50
Recommendation
STRONG BUY
Ethical Screen
Business ActivityPASS
Debt Ratio (0.04%)PASS
Cash Ratio (0.04%)PASS
Receivables Ratio (0.00%)PASS
Revenue Ratio (0.00%)PASS
OverallPASS
Score Valuation: 55.0
Score Quality: 76.0
Score Combined: 53.2
Fair Value Est: $112.29 · Margin of Safety: -20.0%

Full Analysis

Opportunity scores, earnings history, insider transactions, institutional holders, analyst consensus, and more.

Unlock with Membership
Opportunity Scores
Valuation87.9
Quality88.0
Cash Flow50.0
Moat50.0
Balance Sheet99.7
Debt Purity87.3
Liquid Purity86.6
Rev Purity100.0
Compliance90.8
Tier: SILVER · Score: 63.1 · Rank: #416
Insider Transactions
No insider transaction data.
Top Institutional Holders
HolderSharesValue% Held
Rhumbline Advisers7.5K$1.1M
Gamma Investing LLC1.7K$238.0K
PNC Financial Services Group, Inc.275.0$38.6K
Salomon & Ludwin, LLC96.0$13.5K
Hantz Financial Services, Inc. 68.0$9.5K
Rmg Wealth Management LLC37.0$5.2K
Nbc Securities, Inc. 10.0$1.4K
Ancora Advisors, LLC4.0$561.0
Analyst Recommendations
3 Months Ago
2
2 analysts
2 Months Ago
2
2 analysts
Last Month
2
2 analysts
Current
2
2 analysts
Strong Buy Buy Hold Sell Strong Sell
Additional Fundamentals
Enterprise Value
$26.6B
Price/Book
2.12
Beta
0.167
Analysts
2
Total Revenue (TTM)
$7.7B
Total Debt
$2.2B
Earnings Growth
+26.3%
Dividend Yield
61.0%
Rec. Mean
1.00

Elite Intelligence

Trade Consideration with position sizing, convergence signals, and risk analysis. Available to Elite members.

Upgrade to Elite
Trade Consideration
The Opportunity
Score 53.2 (P81 — top 19.0% of scored tickers). Moderate Moat. Ethical PASS. 2 analysts at Strong Buy.
Price: $140.35 | Target: $163.50 (+16%) | Fair Value: $112.29 (+-20%)
Score
53
Moat
MODERATE
Conviction
Standard
Upside
+16%
The Fundamentals
Revenue Growth+26.6%
Profit Margin20.1%
ROE14.9%
Forward P/E18.7
Market Cap$53.5B
Position Sizing Scenarios
Stop: $119.30 (-15%) | Entry: $140.35
SharesCostProfit to TargetR:R
To Consensus ($163.50, 2 analysts)
10$1,403.50+$231.50 (16%)1.1R
50$7,017.50+$1,157.50 (16%)1.1R
100$14,035.00+$2,315.00 (16%)1.1R
To Fair Value ($112.29)
10$1,403.50+$-280.60 (-20%)-1.3R
50$7,017.50+$-1,403.00 (-20%)-1.3R
100$14,035.00+$-2,806.00 (-20%)-1.3R
Risk Factors
  • No elevated risk flags in current data
The Verdict
UCB SA passes all ethical screens, holds a moderate competitive moat, and is growing revenue at +26.6%.
Quantitative Grade

A single score combining all analytical layers below. A is strongest, D is weakest.

B
Quant Score
62.5
Risk Grade
LOW_RISK
Layers
7
Risk Profile

How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.

VaR 95%
-3.3%
worst expected daily loss, 19 in 20 days
CVaR 95%
-5.1%
avg loss on the worst 5% of days
Annual Volatility
Sortino Ratio
1.42
above 1.0 is good
Max Drawdown
-28.6%
Worst Day
Forward Outlook

Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.

30d Prob Up
90d Prob Up
Median Return 30d
Liquidity Score
72
Liquidity Grade
LIQUID
Trend & Momentum

What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?

Kalman Trend
Trend Strength
Momentum Signal
HMM Regime
RSI Signal
Technical Signals

Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.

MA Crossover
ABOVE_200
Bollinger Position
NEAR_UPPER
Beta
Relative Volume
0.7x
Short Interest
Financial Health

Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.

Altman Z-Score
below 1.81 = distress zone
Piotroski F-Score
Earnings Beat Rate
Earnings Consistency
Correlations

These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.

Most Correlated
TickerCorrelation
AZN0.412
NVS0.404
NOVN.SW0.391
GSK0.375
HQH0.364
Inverse Correlated
TickerCorrelation
LPTVQ-0.250
MLTX-0.242
HMR-0.189
BNO-0.187
WBI-0.183
Seasonality

Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.

Best Day
Monday
Worst Day
Thursday
Best Month
Jul
Worst Month
Apr
Fri-Mon Effect
-0.16944542952013655
Momentum Rankings

How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.

1M Return
+1.9%
3M Return
-10.5%
6M Return
+9.0%
12M Return
+57.5%
Momentum Rank
#2002
Momentum Signal
UP

Get our daily market read free. Join thousands of traders.

Free Explorer Access